180 related articles for article (PubMed ID: 12585373)
1. Aplasia cutis congenita and antithyroid drugs.
Izhar R; Ghani T
J Pak Med Assoc; 2002 Nov; 52(11):526-8. PubMed ID: 12585373
[No Abstract] [Full Text] [Related]
2. [A case of aplasia cutis congenita following in utero exposure to carbimazole].
Kojmane W; Atmani S
Ann Dermatol Venereol; 2020 Jan; 147(1):76-77. PubMed ID: 31818499
[No Abstract] [Full Text] [Related]
3. Carbimazole embryopathy: implications for the choice of antithyroid drugs in pregnancy.
Bowman P; Osborne NJ; Sturley R; Vaidya B
QJM; 2012 Feb; 105(2):189-93. PubMed ID: 21258054
[TBL] [Abstract][Full Text] [Related]
4. [Aplasia cutis congenita and antithyroid drugs during pregnancy: Case series and literature review].
Sachs C; Tebacher-Alt M; Mark M; Cribier B; Lipsker D
Ann Dermatol Venereol; 2016; 143(6-7):423-35. PubMed ID: 27033749
[TBL] [Abstract][Full Text] [Related]
5. Antenatal carbimazole and choanal atresia: a new embryopathy.
Wolf D; Foulds N; Daya H
Arch Otolaryngol Head Neck Surg; 2006 Sep; 132(9):1009-11. PubMed ID: 16982979
[TBL] [Abstract][Full Text] [Related]
6. Choanal atresia: the result of maternal thyrotoxicosis or fetal carbimazole?
Barwell J; Fox GF; Round J; Berg J
Am J Med Genet; 2002 Jul; 111(1):55-6; discussion 54. PubMed ID: 12124735
[TBL] [Abstract][Full Text] [Related]
7. Leucopenia and atrial fibrillation: rare presentations of thyrotoxicosis in the first trimester.
Oliver R; Nama VV; Howard RJ; Nikookam KH
J Obstet Gynaecol; 2007 Jul; 27(5):521-3. PubMed ID: 17701808
[No Abstract] [Full Text] [Related]
8. [A new possible phenotype of carbimazole embryopathy: A case report].
Mellerio H; Gay CL; Forest MG; Orgiazzi J; Nicolino M
Arch Pediatr; 2010 May; 17(5):511-6. PubMed ID: 20395117
[TBL] [Abstract][Full Text] [Related]
9. Carbimazole embryopathy: an emerging phenotype.
Foulds N; Walpole I; Elmslie F; Mansour S
Am J Med Genet A; 2005 Jan; 132A(2):130-5. PubMed ID: 15578620
[TBL] [Abstract][Full Text] [Related]
10. Birth defects observed with maternal carbimazole treatment: Six cases reported to Nice's Pharmacovigilance Center.
Koenig D; Spreux A; Hiéronimus S; Chichmanian RM; Bastiani F; Fénichel P; Brucker-Davis F
Ann Endocrinol (Paris); 2010 Dec; 71(6):535-42. PubMed ID: 20934171
[TBL] [Abstract][Full Text] [Related]
11. Aplasia cutis congenita after methimazole exposure in utero successfully treated with basic fibroblast growth factor.
Abe M; Syuto T; Yokoyama Y; Ishikawa O
Int J Dermatol; 2010 Mar; 49(3):334-5. PubMed ID: 20465676
[No Abstract] [Full Text] [Related]
12. Pregnancy complicated by thyrotoxicosis.
Gopeesingh T; Adam M; Roopnarinesingh S
West Indian Med J; 1983 Jun; 32(2):88-90. PubMed ID: 6193648
[No Abstract] [Full Text] [Related]
13. Carbimazole embryopathy.
El Guendouz F; Hammoune N; Hommadi A; Zerhouni H; Baizri H
Ann Endocrinol (Paris); 2017 Oct; 78(5):478-480. PubMed ID: 28870708
[No Abstract] [Full Text] [Related]
14. [Teratogenicity of carbimazole].
Velin P; Dupont D; Golkar A
Arch Pediatr; 1998 Nov; 5(11):1289. PubMed ID: 9853073
[No Abstract] [Full Text] [Related]
15. Cholestatic jaundice following carbimazole therapy in an elderly thyrotoxic patient.
Haboubi H; Harris D; Haboubi N
Age Ageing; 2006 May; 35(3):319. PubMed ID: 16638776
[No Abstract] [Full Text] [Related]
16. Maternal thyrotoxicosis and fetal goitre requiring in utero therapy for hypothyroidism and subsequent neonatal therapy for hyperthyroidism.
Groom K; Snowise S; Wheeler B; Mekhail A; Farrand S; Parry E
J Paediatr Child Health; 2013 Jan; 49(1):E102-3. PubMed ID: 23320593
[No Abstract] [Full Text] [Related]
17. [Pemphigoid gestationis and aplasia cutis congenita: report of a case].
Hakimi I; Benabdejlil Y; Ourraï A; Kouach J; Moussaoui D; Deyahni M
Pan Afr Med J; 2014; 19():47. PubMed ID: 25667709
[TBL] [Abstract][Full Text] [Related]
18. Aplasia cutis congenita in surviving co-twin after propylthiouracil exposure in utero.
Löllgen RM; Calza AM; Schwitzgebel VM; Pfister RE
J Pediatr Endocrinol Metab; 2011; 24(3-4):215-8. PubMed ID: 21648296
[TBL] [Abstract][Full Text] [Related]
19. Type V aplasia cutis congenita.
Qureshi UA; Ahmed N
Ann Saudi Med; 2010; 30(2):171-2. PubMed ID: 20220274
[No Abstract] [Full Text] [Related]
20. Aplasia cutis congenita following in utero methimazole exposure.
Baid SK; Merke DP
J Pediatr Endocrinol Metab; 2007 May; 20(5):585-6. PubMed ID: 17642418
[No Abstract] [Full Text] [Related]
[Next] [New Search]
